摘要
目的:观察糖肾一号方对早期糖尿病肾病(DN)微炎症状态的改善情况,评价该方疗效及对血清炎性因子TNF-、MCP-1、ICAM-1、hs-CRP的影响。方法:选取60例早期DN患者,随机分为对照组和治疗组。对照组予以盐酸贝那普利片治疗,治疗组予以盐酸贝那普利片和糖肾一号方治疗,两组同时予以相应基础治疗,检测治疗前后24 h尿蛋白定量、尿白蛋白排泄率、空腹血糖、糖化血红蛋白、低密度脂蛋白、血清炎性因子TNF-、MCP-1、ICAM-1、hs-CRP水平,统计疗效。结果:治疗组总有效率为83.33%,显著高于对照组总有效率的70.00%。治疗后患者24 h尿蛋白定量、尿白蛋白排泄率、低密度脂蛋白、血清炎性因子TNF-、MCP-1、ICAM-1、hs-CRP水平与治疗前相比均明显下降(P<0.01),且治疗组下降水平明显低于对照组(P<0.05)。两组空腹血糖、糖化血红蛋白水平较治疗前均下降(P<0.01),治疗组下降较对照组明显(P<0.01)。结论:糖肾一号方治疗早期糖尿病肾病可能和其改善微炎症状态有关。
Objective:To observe the improvement of micro-inflammatory state of early diabetic nephropathy with Tangshen 1st recipe,evaluate the effect of the prescription and its effects on serum inflammatory factors TNF-α,MCP-1,ICAM-1,hs-CRP.Methods:Sixty patients with early DN were randomly divided into control group and treatment group.The control group was treated with benazepril hydrochloride tablets.The treatment group was treated with benazepril hydrochloride and Tangshen 1st recipe.The two groups were given corresponding basic treatment.The 24 h urine protein quantitation and urinary albumin excretion rate were measured before and after treatment.Fasting blood glucose,glycosylated hemoglobin,low density lipoprotein,serum inflammatory factors TNF-α,MCP-1,ICAM-1,hs-CRP levels,statistical efficacy.Results:The total effective rate of the treatment group was 83.33%,which was significantly higher than the total effective rate of the control group of 70.00%.After treatment,the 24 h urine protein quantitation,urinary albumin excretion rate,low density lipoprotein,serum inflammatory factors TNF-α,MCP-1,ICAM-1,hs-CRP levels were significantly lower than before treatment(P<0.01).and the treatment group decreased.Significantly lower than that the control group(P<0.05).The levels of fasting blood glucose and glycated hemoglobin in the two groups were lower than those before treatment(P<0.01),and the decrease in the treatment group was significantly higher than that in the control group(P<0.01).Conclusion:The treatment of early diabetic nephropathy with Tangshen 1st recipe may be related to its improvement of micro-inflammation.
作者
赵倩倩
王惠玲
苏衍进
ZHAO Qianqian;WANG Huiling;SU Yanjin(Shaanxi University of Traditional Chinese Medicine,Xianyang 712046)
出处
《陕西中医》
2020年第4期443-446,共4页
Shaanxi Journal of Traditional Chinese Medicine
基金
国家自然科学基金青年项目(81704066)
陕西省中医药管理局课题(2019-ZZ-JC040、LCMS038、JCPT005)
陕西省咸阳市科技局课题(2014K04-19)